Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CMPX market cap is 214.64M. The company's latest EPS is USD -0.3088 and P/E is -5.05.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.93M | 0 | 0 | 0 | 850k |
| Operating Income | -9.4M | -11.93M | -15.39M | -12.77M | -15.04M |
| Net Income | -11.28M | -9.96M | -13.42M | -10.79M | -13.08M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -32k | -27.81M | -81.88M | -41.66M | -50.36M |
| Net Income | -37k | -29.5M | -82.18M | -39.23M | -42.49M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 179.18M | 170.04M | 156.88M | 161.14M | 155.61M |
| Total Liabilities | 10.9M | 9.99M | 8.34M | 4.08M | 9.51M |
| Total Equity | 168.29M | 160.05M | 148.54M | 157.06M | 146.1M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4k | 51.91M | 153.76M | 199.65M | 156.88M |
| Total Liabilities | 112k | 11.97M | 13.68M | 18.01M | 8.34M |
| Total Equity | -108k | 39.95M | 140.08M | 181.64M | 148.54M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.34M | -28.26M | -40.62M | -13.89M | -24.64M |
| Investing | 3.6M | 20.65M | 26.97M | -4.1M | 2.38M |
| Financing | 3.07M | 3.09M | 2.94M | 17.43M | 17.43M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31k | -26.8M | -19.67M | -34.13M | -40.62M |
| Investing | N/A | 38k | -1.77M | -151.2M | 26.97M |
| Financing | 31k | 48.54M | 118.61M | 75.76M | 2.94M |
| Market Cap | 214.64M |
| Price to Earnings Ratio | -5.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.86 |
| Price to Book Ratio | 1.45 |
| Dividend Yield | - |
| Shares Outstanding | 137.59M |
| Average Volume (1 week) | 604.44k |
| Average Volume (1 Month) | 518.1k |
| 52 Week Change | -8.77% |
| 52 Week High | 2.34 |
| 52 Week Low | 0.765 |
| Spread (Intraday) | 0.02 (1.27%) |
| Company Name | Compass Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.compasstherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
